首页> 外文OA文献 >Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting, stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study, drug-use surveillance in Japan

【2h】

Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting, stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study, drug-use surveillance in Japan

机译：基础支持的口服治疗（BOT）在真实临床环境中具有胰岛素甘油的疗效和安全评估，通过伴随口服给药的抗糖尿病（OAD）方案分层，包括二肽基肽酶-4抑制剂（DPP-4i）：Aloha2的细胞分析研究，日本的药用监测

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shoko Tsukube; Takashi Kadowaki; Masato Odawara;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus (R) to Oral Hypoglycemic Agents (ALOHA) study [J] . Odawara Masato, Kadowaki Takashi, Naito Yusuke Journal of diabetes and its complications . 2015,第1期

机译：基础胰岛素支持的甘精胰岛素口服治疗在日本无胰岛素的2型糖尿病患者中是否有微血管并发症的有效性和安全性：观察性，非干预性，24周随访附加Lantus（R）的亚分析）进行口服降糖药（ALOHA）研究
2. Safety and Efficacy of Combination Therapy with Insulin Glargine and Oral Hypoglycaemic Agents Including DPP-4 Inhibitors in Japanese T2DM Patients: ALOHA 2 Study, a Post-Marketing Surveillance for Lantus? [J] . Masayuki Kobayashi, Shoko Tsukube, Yukio Ikeda, Journal of Diabetes Mellitus . 2014,第4期

机译：在日本T2DM患者中联合使用甘精胰岛素和口服降血糖药（包括DPP-4抑制剂）联合治疗的安全性和有效性：ALOHA 2研究，Lantus的上市后监测？
3. Dosing of insulin glargine to achieve the treatment target in Japanese type 2 diabetes on a basal supported oral therapy regimen in real life: ALOHA study subanalysis [J] . OdawaraM., OhtaniT., KadowakiT. Diabetes technology & therapeutics . 2012,第7期

机译：在现实生活中通过基础支持的口服治疗方案给予甘精胰岛素剂量以达到日本2型糖尿病的治疗目标：ALOHA研究亚分析
4. Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i): subanalysis of the ALOHA2 study drug-use surveillance in Japan [O] . Shoko Tsukube, Takashi Kadowaki, Masato Odawara 2016

机译：甘精胰岛素在现实生活中的基础支持口服治疗（BOT）的疗效和安全性评估按口服降糖药（OAD）方案（包括二肽基肽酶-4抑制剂（DPP-4i））进行分层：ALOHA2的亚分析研究日本的毒品使用监视
5. Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study [O] . Odawara Masato, Kadowaki Takashi, Naito Yusuke 2015

机译：基础胰岛素支持的甘精胰岛素口服治疗在日本无胰岛素的2型糖尿病患者中是否有微血管并发症的有效性和安全性：观察性，非干预性，24周随访Add-onLantus®的亚分析口服降糖药（ALOHA）研究

著录项

引文网络

相似文献

相关主题

期刊订阅